Brief Review of the Role of Glycogen Synthase Kinase-3β in Amyotrophic Lateral Sclerosis
2011

The Role of GSK-3β in ALS

publication Evidence: moderate

Author Information

Author(s): Koh Seong-Ho, Baek Wonki, Kim Seung H.

Primary Institution: Department of Neurology, College of Medicine Hanyang University

Hypothesis

The disturbance of signaling proteins upstream of GSK-3β might cause overactivation or overexpression of GSK-3β in ALS.

Conclusion

GSK-3β plays extremely important roles in motoneuronal cell death related to ALS, and the development of specific GSK-3 inhibitors might be an effective strategy for the treatment of ALS.

Supporting Evidence

  • GSK-3β is increased in the thoracic spinal cord tissue of patients with sporadic ALS.
  • Inhibition of GSK-3β reduces motor neuronal cell death in ALS models.
  • GSK-3β inhibition can suppress disease progression of ALS in both in vitro and in vivo models.

Takeaway

GSK-3β is a protein that can cause nerve cells to die in ALS, and finding ways to block it could help treat the disease.

Methodology

This is a review article discussing the role of GSK-3β in ALS based on various studies.

Limitations

The review does not provide new experimental data and relies on existing literature.

Digital Object Identifier (DOI)

10.1155/2011/205761

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication